These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 39026851)
21. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase. Freidel MR; Armen RS PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235 [TBL] [Abstract][Full Text] [Related]
22. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Yu MS; Lee J; Lee JM; Kim Y; Chin YW; Jee JG; Keum YS; Jeong YJ Bioorg Med Chem Lett; 2012 Jun; 22(12):4049-54. PubMed ID: 22578462 [TBL] [Abstract][Full Text] [Related]
23. Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro. Lu L; Peng Y; Yao H; Wang Y; Li J; Yang Y; Lin Z Antiviral Res; 2022 Oct; 206():105389. PubMed ID: 35985407 [TBL] [Abstract][Full Text] [Related]
24. Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study. Vivek-Ananth RP; Krishnaswamy S; Samal A Mol Divers; 2022 Feb; 26(1):429-442. PubMed ID: 34117992 [TBL] [Abstract][Full Text] [Related]
25. Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of Mehyar N J Virus Erad; 2023 Jun; 9(2):100327. PubMed ID: 37363132 [TBL] [Abstract][Full Text] [Related]
26. Mechanistic insights into bismuth(iii) inhibition of SARS-CoV-2 helicase. Wei X; Chan CL; Zhou Y; Tang K; Chen J; Wang S; Chan JF; Yuan S; Li H; Sun H Chem Sci; 2024 Jul; 15(26):10065-10072. PubMed ID: 38966375 [TBL] [Abstract][Full Text] [Related]
27. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity. Yue K; Yao B; Shi Y; Yang Y; Qian Z; Ci Y; Shi L Biochem Biophys Res Commun; 2022 Apr; 601():129-136. PubMed ID: 35245742 [TBL] [Abstract][Full Text] [Related]
28. Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex. Kuzikov M; Reinshagen J; Wycisk K; Corona A; Esposito F; Malune P; Manelfi C; Iaconis D; Beccari A; Tramontano E; Nowotny M; Windshügel B; Gribbon P; Zaliani A Virus Res; 2024 May; 343():199356. PubMed ID: 38490582 [TBL] [Abstract][Full Text] [Related]
29. Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication. Corona A; Madia VN; De Santis R; Manelfi C; Emmolo R; Ialongo D; Patacchini E; Messore A; Amatore D; Faggioni G; Artico M; Iaconis D; Talarico C; Di Santo R; Lista F; Costi R; Tramontano E Antiviral Res; 2023 Sep; 217():105697. PubMed ID: 37562607 [TBL] [Abstract][Full Text] [Related]
30. Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase. White MA; Lin W; Cheng X J Phys Chem Lett; 2020 Nov; 11(21):9144-9151. PubMed ID: 33052685 [TBL] [Abstract][Full Text] [Related]
31. Discovery of Zafirlukast as a novel SARS-CoV-2 helicase inhibitor using in silico modelling and a FRET-based assay. Mehyar N; Mashhour A; Islam I; Alhadrami HA; Tolah AM; Alghanem B; Alkhaldi S; Somaie BA; Al Ghobain M; Alobaida Y; Alaskar AS; Boudjelal M SAR QSAR Environ Res; 2021 Dec; 32(12):963-983. PubMed ID: 34818959 [TBL] [Abstract][Full Text] [Related]
32. ATPase and helicase activities of porcine epidemic diarrhea virus nsp13. Ren J; Ding Z; Fang P; Xiao S; Fang L Vet Microbiol; 2021 Jun; 257():109074. PubMed ID: 33940460 [TBL] [Abstract][Full Text] [Related]
33. Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors. El Hassab MA; Eldehna WM; Al-Rashood ST; Alharbi A; Eskandrani RO; Alkahtani HM; Elkaeed EB; Abou-Seri SM J Enzyme Inhib Med Chem; 2022 Dec; 37(1):563-572. PubMed ID: 35012384 [TBL] [Abstract][Full Text] [Related]
34. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase. Mickolajczyk KJ; Shelton PMM; Grasso M; Cao X; Warrington SR; Aher A; Liu S; Kapoor TM bioRxiv; 2020 Jul; ():. PubMed ID: 32766580 [TBL] [Abstract][Full Text] [Related]
35. Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase. Abidi SH; Almansour NM; Amerzhanov D; Allemailem KS; Rafaqat W; Ibrahim MAA; la Fleur P; Lukac M; Ali S Sci Rep; 2021 May; 11(1):10290. PubMed ID: 33986405 [TBL] [Abstract][Full Text] [Related]
36. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts. Shu T; Huang M; Wu D; Ren Y; Zhang X; Han Y; Mu J; Wang R; Qiu Y; Zhang DY; Zhou X Virol Sin; 2020 Jun; 35(3):321-329. PubMed ID: 32500504 [TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1. Fung SY; Siu KL; Lin H; Chan CP; Yeung ML; Jin DY Cell Biosci; 2022 Mar; 12(1):36. PubMed ID: 35317858 [TBL] [Abstract][Full Text] [Related]
39. Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase. Zhang C; Yu J; Deng M; Zhang Q; Jin F; Chen L; Li Y; He B Molecules; 2024 May; 29(10):. PubMed ID: 38792162 [TBL] [Abstract][Full Text] [Related]
40. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase. Mickolajczyk KJ; Shelton PMM; Grasso M; Cao X; Warrington SE; Aher A; Liu S; Kapoor TM Biophys J; 2021 Mar; 120(6):1020-1030. PubMed ID: 33340543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]